PASG
Passage Bio, Inc.
4.58
2 x 3.43
2 x 5.79
bid
ask
-
0.30
6.15%
2 @ 08:27 AM
4.50 -0.08 (1.65%)
| Ytd | -61.19% | |
| 1y | -43.60% |
4.42
day range
4.92
3.29
52 week range
20.00
| Open | 4.92 | Prev Close | 4.88 | Low | 4.42 | High | 4.92 | Mkt Cap | 14.71M |
| Vol | 57.70K | Avg Vol | 116.37K | EPS | -11.84 | P/E | N/A | Forward P/E | -1.30 |
| Beta | 1.20 | Short Ratio | 6.61 | Inst. Own | 59.68% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 03-03 | 50-d Avg | 5.32 | 200-d Avg | 8.33 | 1yr Est | 8.00 |
| Income Statement | |||
| Operating Expenses | 7.56M | ||
| Research and Development Expense | 4.09M | ||
| Selling, General and Administrative Expense | 4.79M | ||
| Operating Income | -7.56M | ||
| Net Income | -7.56M | ||
| Net Income Common Stock | -7.56M | ||
| Net Income Common Stock (USD) | -7.56M | ||
| Consolidated Income | -7.56M | ||
| Earnings per Basic Share | -2.36 | ||
| Earnings per Basic Share (USD) | -2.36 | ||
| Earnings per Diluted Share | -2.36 | ||
| Earning Before Interest & Taxes (EBIT) | -7.56M | ||
| Earning Before Interest & Taxes (USD) | -7.56M | ||
| Weighted Average Shares | 3.21M | ||
| Weighted Average Shares Diluted | 3.21M | ||
| Balance Sheet | |||
| Cash and Equivalents | 33.34M | ||
| Cash and Equivalents (USD) | 33.34M | ||
| Current Assets | 34.74M | ||
| Property, Plant & Equipment Net | 1.48M | ||
| Total Assets | 36.46M | ||
| Debt Current | 1.15M | ||
| Total Debt | 5.76M | ||
| Current Liabilities | 20.10M | ||
| Debt Non-Current | 4.61M | ||
| Total Liabilities | 24.71M | ||
| Accumulated Retained Earnings (Deficit) | -712.32M | ||
| Shareholders Equity | 11.75M | ||
| Shareholders Equity (USD) | 11.75M | ||
| Assets Non-Current | 1.72M | ||
| Total Debt (USD) | 5.76M | ||
| Liabilities Non-Current | 4.61M | ||
| Trade and Non-Trade Payables | 1.31M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 129.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -12.97M | ||
| Capital Expenditure | 20.00K | ||
| Net Cash Flow from Investing | 20.00K | ||
| Net Cash Flow from Operations | -12.99M | ||
| Share Based Compensation | 556.00K | ||